Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types



Newsletter Article


Could Sanders' Plan to Lower Drug Prices Backfire?

Sen. Bernie Sanders' bill threatening to cut pharmaceutical companies' patent protections if their drug prices are too high has been hailed by some patient advocates as one of the first solid solutions to one of the healthcare industry's most talked about issues. But drug industry insiders and analysts warn the loss of revenue caused by the Vermont independent lawmaker's plan could drive pharmaceutical companies to invest less in developing breakthrough medications. " (Steven Ross Johnson, Modern Healthcare)

Publication Details